Max Mousseron Institute of Biomolecules (IBMM)
The IBMM conducts research on biomolecules (lipids, sugars, proteins, and DNA/RNA), which are the building blocks of life. This research, at the intersection of chemistry and biology, contributes to a better understanding of physiological and pathophysiological mechanisms, as well as to the development of innovative tools for healthcare: new, more effective treatments (for cancer, cardiovascular diseases, and neurodegenerative diseases), new medical devices, new approaches in cosmetology, and new diagnostic systems.
The IBMM teams' areas of expertise include:
- the design of biomolecules and their derivatives using molecular modeling, and their synthesis using more efficient, environmentally friendly methods;
- the development of analytical methods for characterizing biomolecules and analyzing them in biological systems;
- in vitro pharmacological, toxicological, and biological studies of these biomolecules to validate their properties and select the most promising ones for further development into new therapeutic and diagnostic systems and devices;
- The IBMM’s expertise makes it a unique laboratory for commercializing its research, which has led, in particular, to the launch of two drugs (Macrilen, Sébivo) and the creation of several companies.
Immersion at IBMM provides a unique educational experience for students who wish to tackle the future challenges facing the living world.
Label:Joint Research Unit Research UMR)
; Primary Supervising Institutions: CNRS, UM,ENSCM
; Research Cluster:Chemistry
; Doctoral Schools:BALARD Chemical Sciences;Chemical and Biological Sciences for Health
; HAL Portal: the unit’s publications
